Cargando…

Available COVID-19 serial seroconversion panel for validation of SARS-CoV-2 antibody assays.

Seroconversion panels are an important tool for investigating antibody responses and developing serological assays. A seroconversion panel was generated from a single SARS-CoV-2 positive plasma donor over 87 days. This seroconversion panel was tested against 6 SARS-CoV-2 antibody tests (IgG, IgM, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belda, Francisco, Lopez-Martinez, Monica, Torres, Nerea, Cherenzia, Robin, Crowley, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990520/ https://www.ncbi.nlm.nih.gov/pubmed/33596485 http://dx.doi.org/10.1016/j.diagmicrobio.2021.115340

Ejemplares similares

Seroconversion panels demonstrate anti-SARS-CoV-2 antibody development after administration of the mRNA-1273 vaccine
por: Belda, Francisco, et al.
Publicado: (2022)

Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
por: Tuaillon, E, et al.
Publicado: (2020)

SARS-CoV-2 antibody seroconversion in care home
por: Shang, Joan, et al.
Publicado: (2020)

SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS
por: Buchholtz, Marie-Luise, et al.
Publicado: (2021)

A serological assay to detect SARS-CoV-2 seroconversion in humans
por: Amanat, Fatima, et al.
Publicado: (2020)

A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students
por: Lee, Christine C., et al.
Publicado: (2022)

Timeline of heparin‐induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay
por: Warkentin, Theodore E., et al.
Publicado: (2019)

Difficulties of Identifying the Early HIV Antibody Seroconversion Period Depending on the Confirmatory Assay
por: Stefic, Karl, et al.
Publicado: (2020)

Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay
por: Murray, Matthew J., et al.
Publicado: (2021)

SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays
por: Allen, Niamh, et al.
Publicado: (2021)

SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients
por: Algaissi, Abdullah, et al.
Publicado: (2020)

A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion
por: Azad, Taha, et al.
Publicado: (2021)

Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies
por: Wong, Lydia Su Yin, et al.
Publicado: (2023)

Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies
por: Hashem, Anwar M., et al.
Publicado: (2020)

Clinical Evaluation of an Immunochromatographic-Based IgM/IgG Antibody Assay (GenBody™ COVI040) for Detection of Antibody Seroconversion in Patients with SARS-CoV-2 Infection
por: Kim, Doyeong, et al.
Publicado: (2021)

Comparison of six commercially available SARS-CoV-2 antibody assays—Choice of assay depends on intended use
por: Nilsson, Anna Christine, et al.
Publicado: (2021)

SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup
por: Stadlbauer, Daniel, et al.
Publicado: (2020)

Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays
por: Bachman, Christine M., et al.
Publicado: (2021)

A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactions
por: Laing, Eric, et al.
Publicado: (2020)

Longitudinal SARS-CoV-2 Seroconversion Course and Antibody Levels by Blood Groups in Convalescent Plasma Donors in Turkey
por: Karaca, Aziz, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays
por: Yun, Sojeong, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence, seroconversion and neutralizing antibodies in a systemic lupus erythematosus cohort and comparison to controls
por: Mathew, Hannah R, et al.
Publicado: (2021)

Evaluating SARS-CoV-2 Seroconversion Following Relieve of Confinement Measures
por: Gonçalves, Juliana, et al.
Publicado: (2020)

SARS-COV-2 INFECTION AND SEROCONVERSION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
por: Ruan, Wenly, et al.
Publicado: (2021)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Can vitamin D status influence seroconversion to SARS-COV2 vaccines?
por: Shahini, Endrit, et al.
Publicado: (2022)

Seroconversion after Inactive SARS-CoV-2 Vaccination and Obesity: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Healthcare Worker Seroconversion in SARS Outbreak
por: Chow, Pierce K. H., et al.
Publicado: (2004)

Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
por: Jiang, Chuanhao, et al.
Publicado: (2020)

Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population
por: González-Stegmaier, R., et al.
Publicado: (2021)

Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals
por: Egia-Mendikute, Leire, et al.
Publicado: (2021)

SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response
por: Masiá, Mar, et al.
Publicado: (2021)

Reduction of the HIV Seroconversion Window Period and False Positive Rate by Using ADVIA Centaur HIV Antigen/Antibody Combo Assay
por: Lee, Kyunghoon, et al.
Publicado: (2013)

Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients
por: Spencer, Elizabeth A, et al.
Publicado: (2021)

Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer
por: Trontzas, Ioannis P., et al.
Publicado: (2022)

Dynamics of anti-SARS-CoV-2 seroconversion in individual patients and at the population level
por: Szewczyk-Dąbrowska, Alina, et al.
Publicado: (2022)

Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion
por: Jay, Cecilia, et al.
Publicado: (2023)

Corrigendum: Can vitamin D status influence seroconversion to SARS-COV2 vaccines?
por: Shahini, Endrit, et al.
Publicado: (2023)

Patterns of negative seroconversion in ongoing surveys of SARS-CoV-2 antibodies among workers in New York’s largest healthcare system
por: Sembajwe, Grace, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_54f9s6k7nuued581jfpgqi9rg7